142187-88-0

• 

• Basic information

  1. Product Name: 9-(4,5-bishydroxymethylcyclopent-2-en-1-yl)-9H-adenine
  2. Synonyms: 9-(4,5-bishydroxymethylcyclopent-2-en-1-yl)-9H-adenine
  3. CAS NO:142187-88-0
  4. Molecular Formula: C12H15 N5 O2
  5. Molecular Weight: 0
  6. EINECS: N/A
  7. Product Categories: N/A
  8. Mol File: 142187-88-0.mol
  9. Article Data: 5

• Chemical Properties

  1. Melting Point: N/A
  2. Boiling Point: 556.2°Cat760mmHg
  3. Flash Point: 290.2°C
  4. Appearance: /
  5. Density: 1.66g/cm³
  6. Vapor Pressure: 3.32E-13mmHg at 25°C
  7. Refractive Index: 1.8
  8. Storage Temp.: N/A
  9. Solubility: N/A
  10. CAS DataBase Reference: 9-(4,5-bishydroxymethylcyclopent-2-en-1-yl)-9H-adenine(CAS DataBase Reference)
  11. NIST Chemistry Reference: 9-(4,5-bishydroxymethylcyclopent-2-en-1-yl)-9H-adenine(142187-88-0)
  12. EPA Substance Registry System: 9-(4,5-bishydroxymethylcyclopent-2-en-1-yl)-9H-adenine(142187-88-0)

• Safety Data

  1. Hazard Codes: N/A
  2. Statements: N/A
  3. Safety Statements: N/A
  4. WGK Germany:
  5. RTECS:
  6. HazardClass: N/A
  7. PackingGroup: N/A
  8. Hazardous Substances Data: 142187-88-0(Hazardous Substances Data)

• Suppliers
• Usage
• Upstream product
• Downstream Products
• Article

142187-88-0 Suppliers

Recommended suppliersmore

• Product
• FOB Price
• Min.Order
• Supply Ability
• Supplier
• Contact Supplier

142187-88-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 142187-88-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,1,8 and 7 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 142187-88:
(8*1)+(7*4)+(6*2)+(5*1)+(4*8)+(3*7)+(2*8)+(1*8)=130
130 % 10 = 0
So 142187-88-0 is a valid CAS Registry Number.

InChI:InChI=1/C12H15N5O2/c13-11-10-12(15-5-14-11)17(6-16-10)9-2-1-7(3-18)8(9)4-19/h1-2,5-9,18-19H,3-4H2,(H2,13,14,15)/t7-,8-,9-/m0/s1

142187-88-0Upstream product

• 182689-60-7 Acetic acid (1R,4S,5R)-4-hydroxymethyl-5-methoxymethoxymethyl-cyclopent-2-enylmethyl ester 
• 182689-70-9 9-((1R,4S,5R)-4,5-Bis-methoxymethoxymethyl-cyclopent-2-enyl)-9H-purin-6-ylamine 
• 140440-30-8 7-syn-<(benzyloxy)methyl>-2-azabicyclo<2.2.1>hept-5-en-3-one 
• 140440-37-5 (+/-)-9-<5'α-<(benzyloxy)methyl>-4'β-(hydroxymethyl)cyclopent-2'-en-1'β-yl>-6-chloropurine 
• 140440-36-4 (+/-)-5-amino-4-<<5'α-<(benzyloxy)methyl>-4'β-(hydroxymethyl)cyclopent-2'-en-1'β-yl>amino>-6-chloropyrimidine 
• 140440-33-1 7-syn-<(benzyloxy)methyl>-2-(ethoxycarbonyl)-2-azabicyclo<2.2.1>hept-5-en-3-one 
• 140440-34-2 ethyl (+/-)-N-<5α-<(benzyloxy)methyl>-4β-(hydroxymethyl)cyclopent-2-en-1β-yl>carbamate 
• 140440-35-3 (+/-)-5α-<(benzyloxy)methyl>-4β-(hydroxymethyl)cyclopent-2-en-1β-ylamine 
• 117624-93-8 (3aS,4R,5S,6aR)-5-(tert-Butyl-dimethyl-silanyloxy)-4-(tert-butyl-dimethyl-silanyloxymethyl)-hexahydro-cyclopenta[b]furan-2-one 
• 143833-71-0 (1R,2S,3R,4S)-4-(tert-Butyl-dimethyl-silanyloxy)-3-(tert-butyl-dimethyl-silanyloxymethyl)-2-(2-hydroxy-ethyl)-cyclopentanol 
• 143833-75-4 Acetic acid (1R,2S,3R,5R)-3-(tert-butyl-dimethyl-silanyloxy)-2-(tert-butyl-dimethyl-silanyloxymethyl)-5-(6-chloro-purin-9-yl)-cyclopentylmethyl ester 
• 143833-73-2 9-[(1R,2R,3S,4R)-4-(tert-Butyl-dimethyl-silanyloxy)-3-(tert-butyl-dimethyl-silanyloxymethyl)-2-vinyl-cyclopentyl]-6-chloro-9H-purine 
• 143833-74-3 [(1R,2S,3R,5R)-3-(tert-Butyl-dimethyl-silanyloxy)-2-(tert-butyl-dimethyl-silanyloxymethyl)-5-(6-chloro-purin-9-yl)-cyclopentyl]-methanol 
• 143833-78-7 Acetic acid (1R,2S,5R)-2-(tert-butyl-dimethyl-silanyloxymethyl)-5-(6-chloro-purin-9-yl)-cyclopent-3-enylmethyl ester 

142187-88-0Downstream Products

142187-88-0Relevant articles and documents

Synthesis of nucleosides and related compounds. XXXI. Resolution of 9-[c- 4, t-5-bis(hydroxymethyl)cyclopent-2-en-r-1-yl]-9H-adenine [(±)-BCA] by means of high-pressure-mediated deamination with adenosine deaminase

Katagiri,Shiraishi,Toyota,Sato,Kaneko,Aikawa

, p. 1027 - 1029 (1993)

Deamination of an anti-human immunodeficiency virus (anti-HIV) carbocyclic adenine nucleoside, 9-[c-4,t-5-bis(hydroxymethyl)cyclopent-2-en-r-1-yl]-9H- adenine (BCA) by adenosine deaminase under a variety of pressures (1 bar- 6kbar) was investigated. It was found that, while (+)-BCA was practically unaffected, the deamination of (-)-BCA was remarkably enhanced under 4 kbar to give the corresponding (-)-hypoxanthine derivative [(-)-BCH)] in nearly 100% ee.

A NOVEL AND EFFICIENT SYNTHESIS OF 9-(c-4,t-5-BISHYDROXYMETHYLCYCLOPENT-2-EN-r-1-YL)-9H-ADENINE (BCA) HAVING ANTI-HIV ACTIVITY FROM NORBORNADIENE

Katagiri, Nobuya,Sato, Hiroshi,Arai, Sachie,Toyota, Akemi,Kaneko, Chikara

, p. 1097 - 1100 (2007/10/02)

9-(c-4, t-5-Bishydroxymethylcyclopent-2-en-r-1-yl)-9H-adenine (BCA: 1), a novel carboxylic nucleoside having significant anti-HIV activity, has been synthesized from norbornadiene.

Synthesis of (1R, 4S, 5R)-9-(4,5-bishydroxy-methylcyclopent-2-en-1-yl)-9H-adenine [(-)-BCA] and selective inhibition of human immunodeficiency virus

Katagiri, Nobuya,Toyota, Akemi,Shiraishi, Takuya,Sato, Hiroshi,Kaneko, Chikara

, p. 3507 - 3510 (2007/10/02)

(1R,4S,5R)-9(4,5-Bishydroxymethylcyclopent-2-en-1-yl)-9H-adenine [(-)-BCA] has been synthesized from (-)-Corey lactone in 11 steps and shown to have potent and selective effects against human immmunodeficiency virus type 1. The result demonstrated that th

Post a RFQ

Cas No.:

Product Name:

Quantity:

Please select Metric Ton KG G Pound L ML

Email:

Company name:

Valid Period:

Detailed Requirements:

• Sample
• MOQ
• GMP
• FDA
• Price
• Urgent purchase

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

Remove

Submit

1

What can I do for you?
Get Best Price

Get Best Price for 142187-88-0 9-(4,5-bishydroxymethylcyclopent-2-en-1-yl)-9H-adenine

Send

Send

Metric Ton KG G Pound L ML

Send

Send